Twin Securities, Inc.
Broker-DealerPosition in APGE — Apogee Therapeutics, Inc.
CIK 1351351
New York, NY
Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,927,600
New position
Shares Held
120,000
first reported quarter
Ownership
0.159%
of shares outstanding
% of Portfolio
8.13%
of 13F equity value
Holder Rank
#72
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Twin Securities, Inc. holds $16,284,253 across 2 Biotechnology names. APGE ranks #1 (97.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
120,000 | $15,927,600 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
26,517 | $356,653 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,927,600 | 120,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||